Implementation of a sexual health clinic in an oncology setting: patient and provider perspectives by Andrew G. Matthew, Taylor Incze, Elisa Stragapede, Steven Guirguis, Sarah E. Neil-Sztramko, Dean S. Elterman

“…Healthcare providers and patients representing selected cancer types (prostate, cervical, ovarian, testicular, bladder, kidney, and head and neck cancer) participated in semi-structured interviews. …”
Get full text

Nomogram models for predicting outcomes in thyroid cancer patients with distant metastasis receiving 131iodine therapy by Shui Jin, Xuemei Ye, Ting Ye, Xinyu Chen, Jianfeng Ji, Jinyu Wang, Xin Zhu, Xiaochun Mao, Takahiro Higuchi, Heqing Yi

Get full text

Relating proton LETd to biological response of parotid and submandibular glands using PSMA-PET in clinical patients by Dirk Wagenaar, Vineet Mohan, Johannes A. Langendijk, Roel J.H.M. Steenbakkers, Wouter V. Vogel, Stefan Both

“…Background and purpose: A recent study investigated the use of PSMA-PET in monitoring loss of secretory cells in salivary glands of head and neck cancer (HNC) patients. Previously, a dose–effect relation has been formulated to the PSMA-PET uptake in salivary glands. …”
Get full text

Maksilektomi Inferior pada Karsinoma Sel Skuamosa Palatum Durum by Sukri Rahman, Bestari Jaka Budiman, Irwan Triansyah, Heru Kurniawan Anwar Kurniawan Anwar

“…</p><p> </p><p><strong>Kata kunci</strong>: Karsinoma sel skuamosa, maksilektomi inferior, radioterapi</p><p> </p><p><strong><em>Abstract</em></strong></p><p><em>Carcinoma of the hard palate is a rare head and neck cancer in which half of it was Squamous Cell Carcinoma. …”
Get full text

Insight into the current practice of ototoxicity monitoring during cisplatin therapy by N. M. Santucci, B. Garber, R. Ivory, M. A. Kuhn, M. Stephen, D. Aizenberg

“…Patients with Head and Neck Cancer (HNC) represented the largest subgroup that received cisplatin (n = 122, 32.2%) and demonstrated higher rates of ototoxicity counseling (n = 103, 84.4%) and pretreatment audiograms (n = 70, 57.4%) compared to the non HNC group (n = 36, 36.2%, P < 0.0001 and n = 22, 8.5%, P < 0.0001). …”
Get full text

Preoperative hemoglobin and perioperative blood transfusion in major head and neck surgery: a systematic review and meta-analysis by Munib Ali, Joseph C. Dort, Khara M. Sauro

“…Understanding the influence of low preoperative hemoglobin (Hgb) on perioperative blood transfusion (PBT) in head and neck cancer (HNC) surgery with free flap reconstruction may help guide clinical practice to reduce inappropriate treatment among these patients. …”
Get full text

Swallowing-related muscle inflammation and fibrosis induced by a single dose of radiation exposure in mice by Shuntaro Soejima, Chia-Hsien Wu, Haruna Matsuse, Mariko Terakado, Shinji Okano, Tsuyoshi Inoue, Yoshihiko Kumai

“…Abstract Background Although radiotherapy is commonly used to treat head and neck cancer, it may lead to radiation-associated dysphagia (RAD). …”
Get full text

Predicting complications of major head and neck oncological surgery: an evaluation of the ACS NSQIP surgical risk calculator by Peter S. Vosler, Mario Orsini, Danny J. Enepekides, Kevin M. Higgins

Get full text

An Efficient 3D Convolutional Neural Network for Dose Prediction in Cancer Radiotherapy from CT Images by Lam Thanh Hien, Pham Trung Hieu, Do Nang Toan

“…The model is developed using the OpenKBP challenge dataset, which consists of 200, 100, and 40 head and neck cancer patients for training, testing, and validation, respectively. …”
Get full text

A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response by Minghan Li, Chang Su, Qianru Wang, Yuetong Chen, Di Jiang, Weijia Wang, Shunjin Chen, Xiangping Li, Ming Fu, Juan Lu

“…Furthermore, we performed in vitro research to validate the significance of ZNF32 in head and neck cancer (HNSC). Our study revealed that ZNF32 was high in various types of cancer, including ACC, BRCA, and others, indicating its important potential as a prognostic biomarker. …”
Get full text

PET-Assessed Metabolic Tumor Volume Across the Spectrum of Solid-Organ Malignancies: A Review of the Literature by Anusha Agarwal, Chase J. Wehrle, Sangeeta Satish, Paresh Mahajan, Suneel Kamath, Shlomo Koyfman, Wen Wee Ma, Maureen Linganna, Jamak Modaresi Esfeh, Charles Miller, David C. H. Kwon, Andrea Schlegel, Federico Aucejo

“…Across various solid tumor malignancies, including lung cancer, head and neck cancer, breast cancer, esophageal cancer, and colorectal cancer, the current literature has demonstrated an association between MTV and various clinical outcomes. …”
Get full text

High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis by Sehhoon Park, Jaeyun Jung, You Jeong Heo

“…The response rate to anti-PD-(L)1 therapy was substantially higher in GC (71.4% vs 25.8%), GBC (50.0% vs 12.5%), head and neck cancer (50.0% vs 11.1%), and melanoma (71.4% vs 50.7%) among TMB-H patients when compared with low TMB (TMB-L) (&lt;10 mt/Mb) patients with statistical significance. …”
Get full text

Frequency and accuracy of intraoperative bone margin sampling for T4a cancers of the head and neck at the QEII Health Sciences Centre: a retrospective chart review by Anna-Claire Lamport, Colin A. MacKay, Martin J. Bullock, S. Mark Taylor, Jonathan R. Trites, Martin Corsten, Matthew H. Rigby

“…Methods A retrospective chart review was conducted including patients with stage T4a head and neck cancer involving bone that underwent primary surgical resection in Nova Scotia between 2009 and 2019. …”
Get full text

ORIGINAL RESEARCH by Ciprian Camil Mireştean, Anda Crişan, Liliana Eleonora Semenescu, Adina Mitrea, Florinel Bădulescu

“…The evolution of the neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio during polychemotherapy in head and neck cancers Imaging of pericardial compressive syndromes – cardiac tamponade in oncologic patients…”
Get full text

Osteoradionecrosis of the Temporal Bone Leading to Cerebellar Abscess by Thomas B. Layton

“…One feared complication of radiotherapy is osteoradionecrosis and is a major obstacle faced in the treatment of head and neck cancers. The case presented here is a rare example of a patient who was successfully treated for SCC of the temporal with both surgical resection and adjuvant radiotherapy who subsequently developed two major complications: first, osteoradionecrosis of the temporal bone that leads to penetrating osteomyelitis; second, the formation of a large cerebellar abscess that required surgical drainage. …”
Get full text

NFIB-Mediated lncRNA PVT1 Aggravates Laryngeal Squamous Cell Carcinoma Progression via the miR-1301-3p/MBNL1 Axis by Tian Tang, Feng Zeng

“…Laryngeal squamous cell carcinoma (LSCC) is one of the most common malignant tumors of head and neck cancers. In the past decades, although the therapy strategies of LSCC have made considerable improvement, the terrible outcomes of LSCC still bring an enormous burden to the world health care system. …”
Get full text

Endovascular Treatment of Vertebral Column Metastases Using Intra-Arterial Cisplatin: Pilot Experience by Bohdan W. Chopko

“…Intra-arterial chemotherapy is an uncommonly used but established treatment for head and neck cancers, retinoblastoma, and glioblastoma. …”
Get full text

Risk of TB disease in individuals with cancer by T. Diefenbach-Elstob, S. Tabrizi, P. Rivest, A. Benedetti, L. Azoulay, K. Schwartzman, C. Greenaway

“…Screening and treatment should be considered for potentially preventable TB (diagnosed more than 6 months post-cancer), particularly in those with respiratory, haematologic, and head and neck cancers.…”
Get full text

Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPV by Michaela Helble, Michaela Helble, Xizhou Zhu, Pratik S. Bhojnagarwala, Kevin Liaw, Yangcheng Gao, Amber Kim, Kelly Bayruns, Madison E. McCanna, Joyce Park, Kylie M. Konrath, Kylie M. Konrath, Sam Garfinkle, Sam Garfinkle, Taylor Brysgel, David B. Weiner, David B. Weiner, Daniel W. Kulp, Daniel W. Kulp

“…This includes cervical, vaginal, vulvar, penile, and anal cancers, as well as head and neck cancers. As such, there is an urgent need to develop effective therapeutic vaccines to drive the immune system’s cellular response against cancer cells. …”
Get full text

Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis by Chunli Huang, Jifeng Liu

“…It is generally believed that the majority of head and neck cancers develop in the mucosal epithelial cells of the mouth, pharynx, and larynx, which is collectively known as head and neck squamous cell carcinoma (HNSC). …”
Get full text